HUE055764T2 - Új pikolinsav származékok és alkalmazásuk intermedierekként - Google Patents

Új pikolinsav származékok és alkalmazásuk intermedierekként

Info

Publication number
HUE055764T2
HUE055764T2 HUE17826574A HUE17826574A HUE055764T2 HU E055764 T2 HUE055764 T2 HU E055764T2 HU E17826574 A HUE17826574 A HU E17826574A HU E17826574 A HUE17826574 A HU E17826574A HU E055764 T2 HUE055764 T2 HU E055764T2
Authority
HU
Hungary
Prior art keywords
intermediates
acid derivatives
picolinic acid
new
new picolinic
Prior art date
Application number
HUE17826574A
Other languages
English (en)
Inventor
Thomas Heinz
Benjamin Martin
Florian Andreas Rampf
Werner Zaugg
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HUE055764T2 publication Critical patent/HUE055764T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE17826574A 2016-12-19 2017-12-18 Új pikolinsav származékok és alkalmazásuk intermedierekként HUE055764T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662436222P 2016-12-19 2016-12-19

Publications (1)

Publication Number Publication Date
HUE055764T2 true HUE055764T2 (hu) 2021-12-28

Family

ID=60953912

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE17826574A HUE055764T2 (hu) 2016-12-19 2017-12-18 Új pikolinsav származékok és alkalmazásuk intermedierekként

Country Status (16)

Country Link
US (1) US10633341B2 (hu)
EP (1) EP3555048B1 (hu)
JP (1) JP7063902B2 (hu)
KR (1) KR102454635B1 (hu)
CN (1) CN110072851B (hu)
AU (1) AU2017381739B2 (hu)
CA (1) CA3044366A1 (hu)
DK (1) DK3555048T3 (hu)
ES (1) ES2891527T3 (hu)
HU (1) HUE055764T2 (hu)
IL (1) IL267042B (hu)
PL (1) PL3555048T3 (hu)
PT (1) PT3555048T (hu)
RU (1) RU2769693C2 (hu)
SI (1) SI3555048T1 (hu)
WO (1) WO2018116139A1 (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11865109B2 (en) 2019-07-15 2024-01-09 Novartis Ag Formulations of (S)-3-amino-6-methoxy-N-(3,3,3-trifluoro-2-hydroxy-2-methylpropyl)-5-(trifluoromethyl)picolinamide
WO2023109939A1 (zh) * 2021-12-17 2023-06-22 苏州晶云药物科技股份有限公司 吡啶类衍生物的晶型及其制备方法
CN115073366A (zh) * 2022-06-08 2022-09-20 都创(重庆)医药科技有限公司 一种基于微通道技术快速制备3-氯吡啶-2-甲酸的方法
CN116396213B (zh) * 2023-04-14 2024-06-14 济南大学 一种2-吡啶甲酸甲酯的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0929524A1 (de) 1996-09-18 1999-07-21 Basf Aktiengesellschaft Pyridinderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von tierischen schädlingen und schadpilzen
BR9713027A (pt) 1996-11-12 2000-01-25 Novartis Ag Derivados de pirazol úteis como herbicidas
EP1582524B1 (en) 2004-04-02 2008-08-13 Ludwig Maximilians Universität Method of preparing organomagnesium compounds
EP1810974A1 (en) 2006-01-18 2007-07-25 Ludwig-Maximilians-Universität München Preparation and use of magnesium amides
KR101390076B1 (ko) * 2006-11-08 2014-04-29 브리스톨-마이어스 스큅 컴퍼니 피리디논 화합물
WO2008119015A2 (en) 2007-03-27 2008-10-02 Sloan-Kettering Institute For Cancer Research Synthesis of thiohydantoins
DE102007022490A1 (de) 2007-05-14 2008-11-20 Ludwig-Maximilians-Universität Bisamid-Zinkbasen
US8247436B2 (en) 2010-03-19 2012-08-21 Novartis Ag Pyridine and pyrazine derivative for the treatment of CF
ES2516165T3 (es) * 2010-07-12 2014-10-30 F. Hoffmann-La Roche Ag 1-hidroxiimino-3-fenil-propanos
WO2013038373A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
WO2013038378A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
ES2558457T3 (es) 2011-09-16 2016-02-04 Novartis Ag Compuestos heterocíclicos para el tratamiento de fibrosis quística
WO2013057711A1 (en) 2011-10-21 2013-04-25 Novartis Ag Quinazoline derivatives as pi3k modulators
MX370140B (es) 2014-06-06 2019-12-03 Astellas Pharma Inc Derivado de 2-acilaminotiazol o sal del mismo.
CN108368084B (zh) 2015-10-01 2020-10-16 百时美施贵宝公司 联芳基激酶抑制剂
MA44489A (fr) 2016-03-25 2019-01-30 Afferent Pharmaceuticals Inc Pyrimidines et variants de celles-ci, et leurs utilisations

Also Published As

Publication number Publication date
JP7063902B2 (ja) 2022-05-09
IL267042A (en) 2019-07-31
JP2020502194A (ja) 2020-01-23
PL3555048T3 (pl) 2021-12-06
KR20190091460A (ko) 2019-08-06
US10633341B2 (en) 2020-04-28
EP3555048A1 (en) 2019-10-23
US20190345107A1 (en) 2019-11-14
IL267042B (en) 2021-12-01
AU2017381739A1 (en) 2019-05-30
ES2891527T3 (es) 2022-01-28
KR102454635B1 (ko) 2022-10-17
SI3555048T1 (sl) 2021-11-30
WO2018116139A1 (en) 2018-06-28
RU2019122609A3 (hu) 2021-02-19
RU2769693C2 (ru) 2022-04-05
CN110072851B (zh) 2023-06-06
DK3555048T3 (da) 2021-10-11
CN110072851A (zh) 2019-07-30
PT3555048T (pt) 2021-09-29
CA3044366A1 (en) 2018-06-28
EP3555048B1 (en) 2021-07-07
AU2017381739B2 (en) 2020-06-11
RU2019122609A (ru) 2021-01-19

Similar Documents

Publication Publication Date Title
HK1254057A1 (zh) 用於製備膽汁酸衍生物的方法和中間體
IL241601B (en) Derivatives of 4-amino-3-chloro-5-fluoro-6-(7-fluoro-h1-indol-6-yl)picolinic acids and their use as herbicides
HK1253581A1 (zh) 經取代的吡啶及使用方法
HRP20190432T1 (hr) Spojevi pladienolid piridina i postupci uporabe
HK1254055A1 (zh) 製備奧貝膽酸及其衍生物的方法
IL267042A (en) New history of picolinic acid and their use as intermediates
IL255054A0 (en) Tetrahydronephthyridinyl propionic acid derivatives and their uses
HK1254367A1 (zh) 新的工藝和中間體
EP3107540A4 (en) Polymorphs of lomitapide and its salts
HK1247196A1 (zh) Scy-078的新型鹽及多晶型物
DK3200779T3 (en) Novel anthranilic acid derivatives
EP3263133B8 (en) Pyridinone compound and use thereof
IL259073A (en) History of abscisic acid - converted at the 3' position
EP3337479A4 (en) NOVEL POLYMORPH OF DOLUTEGRAVIR AND SALTS FROM IT
HUE050178T2 (hu) Piridinon vegyület és alkalmazása
RS59839B1 (sr) Supstituisani derivat pirazolil-pirazola i upotreba istog kao herbicida
GB201513318D0 (en) Novel compounds and their use